Immunotherapy in cancer: novel approaches and future perspectives

Growing understanding of immune cell regulation and the tumour microenvironment is transforming cancer therapy by enabling the development of tailored immunomodulatory agents, novel combination treatments and new immunotherapy targets. As a result, cancer types and stages once considered incurable or requiring radical surgery can now be managed with effective therapeutic combinations that preserve organs, extend survival and improve patients' quality of life. The themed issue of the British Journal of Pharmacology features four review articles that explore recent advancements in cancer immunotherapy and new approaches to overcome challenges in immunotherapy. Furthermore, the issue includes two research articles that present novel antibodies that remodel the tumour immune landscape and novel approaches to reprogram the tumour microenvironment to increase the efficacy of chimeric antigen receptor T-cell therapy (CAR-T) immunotherapy. LINKED ARTICLES: This article is part of a themed issue Immunotherapy in Cancer. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v183.6/issuetoc.